News

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...
Herb Greenberg, 'Herb on the Street' author, joins 'Power Lunch' to discuss Greenberg's thoughts on the terminated partnership between Novo Nordisk and Hims & Hers.
Novo Nordisk (NVO), ... This week, the Trump administration imposed 25% tariffs on imports from Canada and Mexico as well as additional tariffs on Chinese goods, ...
Novo Nordisk is hoping to win approval in Mexico within a year, the company's SVP for international operations, Mike Doustdar, told the WSJ. "I'm very encouraged that this drug will come to many ...
COPENHAGEN, Sept 2 (Reuters) - Novo Nordisk has launched its type 2 diabetes treatment Ryzodeg in Mexico, a combination drug that could reap the company billions in revenue in years to come.
Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Novo Nordisk <NOVOb.CO> has launched its type 2 diabetes treatment Ryzodeg in Mexico, a combination drug that could reap the company billions in revenues in years to come.
Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.